Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein.

Tauopathies include a variety of neurodegenerative diseases associated with the pathological aggregation of hyperphosphorylated tau, resulting in progressive cognitive decline and motor impairment. The underlying mechanism for motor deficits related to tauopathy is not yet fully understood. Here, we use a novel transgenic tau mouse line, Tau 58/4, with enhanced neuron-specific expression of P301S mutant tau to investigate the motor abnormalities in association with the peripheral nervous system. Using stationary beam, gait, and rotarod tests, motor deficits were found in Tau 58/4 mice already 3 months after birth, which deteriorated during aging. Hyperphosphorylated tau was detected in the cell bodies and axons of motor neurons. At the age of 9 and 12 months, significant denervation of the neuromuscular junction in the extensor digitorum longus muscle was observed in Tau 58/4 mice, compared to wild-type mice. Muscle hypotrophy was observed in Tau 58/4 mice at 9 and 12 months. Using electron microscopy, we observed ultrastructural changes in the sciatic nerve of 12-month-old Tau 58/4 mice indicative of the loss of large axonal fibers and hypomyelination (assessed by g-ratio). We conclude that the accumulated hyperphosphorylated tau in the axon terminals may induce dying-back axonal degeneration, myelin abnormalities, neuromuscular junction denervation, and muscular atrophy, which may be the mechanisms responsible for the deterioration of the motor function in Tau 58/4 mice. Tau 58/4 mice represent an interesting neuromuscular degeneration model, and the pathological mechanisms might be responsible for motor signs observed in some human tauopathies.

[1]  Chi Li,et al.  Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Y Ben-Shlomo,et al.  Clinical features and natural history of progressive supranuclear palsy , 2003, Neurology.

[3]  S. Rotshenker The Role of Galectin-3/MAC-2 in the Activation of the Innate-Immune Function of Phagocytosis in Microglia in Injury and Disease , 2009, Journal of Molecular Neuroscience.

[4]  Ann Saada,et al.  Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2 , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  I. Reynolds,et al.  Mitochondrial Trafficking to Synapses in Cultured Primary Cortical Neurons , 2006, The Journal of Neuroscience.

[6]  D. Prvulovic,et al.  Treatment Options for Tauopathies , 2012, Current Treatment Options in Neurology.

[7]  J. Brion,et al.  Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1 , 2004, Neurobiology of Disease.

[8]  R. D'Hooge,et al.  Increased gait variability in mice with small cerebellar cortex lesions and normal rotarod performance , 2013, Behavioural Brain Research.

[9]  R. Hauser,et al.  Diffuse lewy body disease , 2001, Current treatment options in neurology.

[10]  J. Trojanowski,et al.  P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating , 2011, PloS one.

[11]  Kai Zhang,et al.  Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport , 2010, Science.

[12]  B. Sommer,et al.  Expression of APP in transgenic mice: a Comparison of neuron-specific promoters , 1996, Neurobiology of Aging.

[13]  John Q Trojanowski,et al.  Transgenic animal models of tauopathies. , 2005, Biochimica et biophysica acta.

[14]  S. Brady,et al.  Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  Hirotaka Yoshida,et al.  Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein , 2002, The Journal of Neuroscience.

[16]  S. Chandran,et al.  Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis. , 2008, Brain : a journal of neurology.

[17]  L. Tönges,et al.  Axonal degeneration as a therapeutic target in the CNS , 2012, Cell and Tissue Research.

[18]  Mark Ellisman,et al.  Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma , 2011, Proceedings of the National Academy of Sciences.

[19]  E. Mandelkow,et al.  Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses , 2003, Neurobiology of Aging.

[20]  J. Brandt,et al.  Motor signs during the course of Alzheimer disease , 2004, Neurology.

[21]  L. Roth,et al.  Impaired gait pattern as a sensitive tool to assess hypoxic brain damage in a novel mouse model of atherosclerotic plaque rupture , 2015, Physiology & Behavior.

[22]  M. Schliwa,et al.  Structural interaction of cytoskeletal components , 1981, The Journal of cell biology.

[23]  E. Melamed,et al.  The “Dying-Back” Phenomenon of Motor Neurons in ALS , 2011, Journal of Molecular Neuroscience.

[24]  S. Kato,et al.  Loss of dopaminoreceptive neuron causes L-dopa resistant parkinsonism in tauopathy , 2012, Neurobiology of Aging.

[25]  Zhihua Feng,et al.  Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy. , 2012, Human molecular genetics.

[26]  J. Paul Bolam,et al.  Extrinsic Sources of Cholinergic Innervation of the Striatal Complex: A Whole-Brain Mapping Analysis , 2016, Front. Neuroanat..

[27]  L. Poncelet,et al.  Motor deficit in a tauopathy model is induced by disturbances of axonal transport leading to dying-back degeneration and denervation of neuromuscular junctions. , 2015, The American journal of pathology.

[28]  A. Bush,et al.  Motor and cognitive deficits in aged tau knockout mice in two background strains , 2014, Molecular Neurodegeneration.

[29]  I. Grundke‐Iqbal,et al.  Tau pathology in Alzheimer disease and other tauopathies. , 2005, Biochimica et biophysica acta.

[30]  Luigi Ferrucci,et al.  The Neuromuscular Junction: Aging at the Crossroad between Nerves and Muscle , 2014, Front. Aging Neurosci..

[31]  M. Raaben,et al.  Mouse Hepatitis Coronavirus RNA Replication Depends on GBF1-Mediated ARF1 Activation , 2008, PLoS pathogens.

[32]  Jian-Wei Zhu,et al.  Toll-Like Receptor 4 Deficiency Impairs Motor Coordination , 2016, Front. Neurosci..

[33]  G. Bennett,et al.  Terminal arbor degeneration – a novel lesion produced by the antineoplastic agent paclitaxel , 2011, The European journal of neuroscience.

[34]  E. Mandelkow,et al.  Hyperphosphorylation and Aggregation of Tau in Experimental Autoimmune Encephalomyelitis* , 2004, Journal of Biological Chemistry.

[35]  P. Reddy,et al.  Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease , 2011, Brain Research.

[36]  D. Westaway,et al.  Microglial activation in brain lesions with tau deposits: Comparison of human tauopathies and tau transgenic mice TgTauP301L , 2008, Brain Research.

[37]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.

[38]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[39]  F. de Winter,et al.  ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease , 2014, Front. Neurosci..

[40]  F. van Leuven,et al.  Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice* , 2005, Journal of Biological Chemistry.

[41]  Bin Zhang,et al.  Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.

[42]  U. Rutishauser,et al.  Adherens Junctions in Myelinating Schwann Cells Stabilize Schmidt-Lanterman Incisures via Recruitment of p120 Catenin to E-Cadherin , 2005, The Journal of Neuroscience.

[43]  Sylvie M. de Waegh,et al.  Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[44]  K. Ashe,et al.  Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L) , 2005, The Journal of Neuroscience.

[45]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.

[46]  S H Ferris,et al.  Motor/Psychomotor Dysfunction in Normal Aging, Mild Cognitive Decline, and Early Alzheimer's Disease: Diagnostic and Differential Diagnostic Features , 1997, International Psychogeriatrics.

[47]  Hui Zheng,et al.  In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease , 2007, NeuroImage.

[48]  D. Raj,et al.  Priming of microglia in a DNA-repair deficient model of accelerated aging , 2014, Neurobiology of Aging.

[49]  E. Alleva,et al.  Early behavioural markers of disease in P301S tau transgenic mice , 2010, Behavioural Brain Research.

[50]  E. Mandelkow,et al.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.

[51]  Matthias Endres,et al.  Assessing Post-Stroke Behavior in Mouse Models of Focal Ischemia , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[52]  L. Buée,et al.  P1–062: Alzheimer's disease–like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits , 2006, The American journal of pathology.

[53]  V. Melis,et al.  Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer’s disease and frontotemporal lobar degeneration , 2014, Cellular and Molecular Life Sciences.

[54]  Antonia Gutierrez,et al.  Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus , 2011, Acta Neuropathologica.

[55]  D. Williams,et al.  Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule‐associated protein tau , 2006, Internal medicine journal.

[56]  N. Sousa,et al.  Absence of Tau triggers age‐dependent sciatic nerve morphofunctional deficits and motor impairment , 2016, Aging cell.

[57]  G. Shelton,et al.  Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy , 1998, Acta Neuropathologica.

[58]  H. Geerts,et al.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. , 1999, The American journal of pathology.

[59]  U. Frey,et al.  Endogenous Serine Protease Inhibitor Modulates Epileptic Activity and Hippocampal Long-Term Potentiation , 1997, The Journal of Neuroscience.

[60]  M. Spillantini,et al.  Tau gene mutations: dissecting the pathogenesis of FTDP-17. , 2002, Trends in molecular medicine.

[61]  A. Vercelli,et al.  Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy , 2016, Front. Neuroanat..

[62]  J. Trojanowski,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[63]  J. Gal,et al.  Mitochondrial dysfunction in amyotrophic lateral sclerosis. , 2010, Biochimica et biophysica acta.

[64]  J. Silver,et al.  The role of astrocytes in axon guidance during development and repair , 1997 .

[65]  John P. John,et al.  Assessing Neurocognition via Gamified Experimental Logic: A Novel Approach to Simultaneous Acquisition of Multiple ERPs , 2016, Front. Neurosci..

[66]  S. Dunnett,et al.  Tests to assess motor phenotype in mice: a user's guide , 2009, Nature Reviews Neuroscience.

[67]  D. Wilcock,et al.  Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease , 2010, Neuroscience.

[68]  S. Lisney,et al.  Regeneration of unmyelinated axons after injury of mammalian peripheral nerve. , 1989, Quarterly journal of experimental physiology.

[69]  Sameer B. Shah,et al.  Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles , 2013, The Journal of physiology.

[70]  R. Mirsky,et al.  The repair Schwann cell and its function in regenerating nerves , 2016, The Journal of physiology.

[71]  Jada Lewis Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein , 2000, Nature Genetics.

[72]  L. Greensmith,et al.  c-Jun Reprograms Schwann Cells of Injured Nerves to Generate a Repair Cell Essential for Regeneration , 2012, Neuron.